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The human APOBEC3G protein is an innate anti-viral factor that can dominantly inhibit the replication of some endogenous
and exogenous retroviruses. The prospects of purposefully harnessing such an anti-viral defense are under investigation. Here,
long-term co-culture experiments were used to show that porcine endogenous retrovirus (PERV) transmission from pig to
human cells is reduced to nearly undetectable levels by expressing human APOBEC3G in virus-producing pig kidney cells.
Inhibition occurred by a deamination-independent mechanism, likely after particle production but before the virus could
immortalize by integration into human genomic DNA. PERV inhibition did not require the DNA cytosine deaminase activity of
APOBEC3G and, correspondingly, APOBEC3G-attributable hypermutations were not detected. In contrast, over-expression of
the sole endogenous APOBEC3 protein of pigs failed to interfere significantly with PERV transmission. Together, these data
constitute the first proof-of-principle demonstration that APOBEC3 proteins can be used to fortify the innate anti-viral
defenses of cells to prevent the zoonotic transmission of an endogenous retrovirus. These studies suggest that human
APOBEC3G-transgenic pigs will provide safer, PERV-less xenotransplantation resources and that analogous cross-species
APOBEC3-dependent restriction strategies may be useful for thwarting other endogenous as well as exogenous retrovirus
infections.
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APOBEC3G. PLoS ONE 2(9): e893. doi:10.1371/journal.pone.0000893
INTRODUCTION
Viral zoonoses have impacted human populations through the
ages. The 1918 influenza epidemic, the 2003 SARS incident and
the ongoing HIV/AIDS pandemic constitute clear examples of
virus transfer from birds [1], bats [2] and chimpanzees [3].
Domesticated animals can also function as zoonotic intermediates
(e.g., [4,5]). Additional and unprecedented opportunities for
zoonoses occur when live cells, tissues or organs are transplanted
from one species to another [6]. However, despite risks and
technical and immunological challenges, several xenotransplanta-
tion procedures have shown preclinical promise for treating
diabetes, heart, kidney and other human diseases (e.g., [7–9]).
Pigs are favourable xenotransplantation sources because of their
human-like physiology, large litters, short gestation period and
genetic malleability [10]. However, pig to human virus trans-
mission has been a concern since it was shown that porcine
endogenous retroviruses (PERVs) could infect human cells in
culture [6,11–13]. Although PERV transmission has yet to be
documented in xenotransplantation patients, significant concerns
still exist regarding PERV and other potentially pathogenic viruses
[14,15]. Strategies to reduce the likelihood of PERV transmission
have been proposed, such as selective breeding for lower levels of
PERV, RNAi transgenesis to knock-down PERV expression or
systematic deletion of active PERV copies (e.g., [15,16]). The first
two are unlikely to be completely effective or risk-free and the
third, albeit theoretically feasible, may be overly technical and
prohibitively expensive. Therefore, alternative, robust and cost-
effective methods to reduce PERV transmission and possible
xenozoonotic infections are desirable.
APOBEC3G is a single-strand DNA cytosine deaminase best
understood as a potent inhibitor of HIV-1 replication [17–23]. It
can however also inhibit a variety of other exogenous and
endogenous retroviruses/elements (e.g., [17,18,24–29]). APO-
BEC3G engages an assembling retrovirus particle, accesses the
RNA genome-containing virus core and, upon reverse transcription,
deaminates cDNA cytosines to uracils (C-to-U). Catastrophic levels
of uracil either directly inactivate the coding capacity of the virus or
trigger the degradation of the viral DNA. The former manifests as
genomic strand-specificguanine to adenine (G-to-A) hypermutations
(cDNA strand C-to-T transitions). However, in several instances, it is
noteworthy that the deaminase activity of APOBEC3G or other
APOBEC3 proteins is partly or even completely dispensable (e.g.,
HIV-1, hepatitis B virus, L1 and Alu [27–32]).
Interestingly, throughout evolution, the retroviruses of many
mammals appear to have become largely immune to APOBEC3G
or to the APOBEC3G-like proteins of their hosts. HIV-1 expresses
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ubiquitination and degradation [33–36]. Simian immunodeficien-
cy virus (SIV) uses a similar Vif-dependent mechanism [17,26].
Foamy viruses employ an unrelated viral protein called Bet, for
which the precise neutralization mechanism is currently unclear
[37,38]. Murine leukaemia virus (MLV) and human T-lympho-
trophic virus-1 (HTLV-1) may simply avoid APOBEC3 proteins
by preventing encapsidation [26,39,40].
However, cell-based studies have indicated that an APOBEC3
protein from a mammal to which the virus has not yet adapted
may provide an effective strategy for thwarting species-specific
viral counter-defenses. For instance, human APOBEC3G can
potently inhibit the replication of SIV (except isolates such as
SIVcpz which encode a Vif protein closely related to that of HIV-
1), feline foamy virus and MLV (e.g., [17–20,25,26,39,41,42]).
Similarly, mouse APOBEC3 can potently block HIV-1 replication
(regardless of Vif), although it is completely unable to impede the
replication of MLV [26,41]. One of the most dramatic examples
to date used human and mouse APOBEC3 proteins to inhibit the
mobilization of the yeast retrotransposons Ty1 and Ty2 [43,44].
Thus, it is reasonable to hypothesize that cross-species expression
of an APOBEC3 protein may be used to create a powerful barrier
to impede or perhaps even block retrovirus infection. Here, this
rationale is applied to the specific question of whether human
APOBEC3G expression can inhibit the transmission of PERV
from pig to human cells. The results demonstrate that PERV
transmission can be strongly inhibited by APOBEC3G.
RESULTS
A Co-culture Assay to Monitor PERV Transmission
To determine whether expression of human APOBEC3G would
inhibit the transfer of PERV from pig to human cells it was first
necessary to establish a long-term co-culture system. A trans-well
assay was set up to monitor PERV transmission from pig kidney
PK-15 fibroblasts to recipient human embryonic kidney 293T cells
(Figure 1A). These two cell types were used because transmission
from PK-15 to 293 cells had been reported previously [11]. The
trans-well system enabled co-cultures to be sustained for several
weeks, and it facilitated the recovery of each cell type for
downstream analyses. An additional benefit of this co-culture
system (not provided by transient assays) is that it enables the
simultaneous analysis of multiple, endogenous PERV elements,
which are precisely the targets one would want to monitor and
ideally inhibit in (xeno)transplantation procedures.
At each co-culture passage point, surplus human 293T cells
were used to prepare genomic DNA. PERV transmission was
monitored by subjecting these samples to quantitative (Q)-PCR.
PERV-specific pol gene PCR products could be detected in the
human genomic DNA samples after approximately two weeks of
continuous co-culture (Figure 1B). From the point of first detection
onward, the total number of PERV transmissions continued to
increase, averaging 190 new events per day per 50,000 cells (10
5
beta-actin copies; SEM=62; n=5 experiments). Importantly, pig
cells did not breach the 293T cell compartment because Q-PCR
analyses of the same human genomic DNA samples failed to detect
a concomitant transfer of pig genomic DNA (Figure 1B; also see
Online Figure S1 for PERV pol gene Q-PCR standard curves,
representative PERV-specific datasets and human beta-actin
controls). Moreover, PERV copy number did not increase over
a two week interval when infected 293T cells were grown in
isolation, indicating that PERV was not replicating in the human
cells and that the majority of the observed transmission events
were derived from the PK-15 cells (i.e., new events). These results
combine to indicate that the trans-well assay provided a robust
system for monitoring bona fide zoonotic PERV transmissions.
Human APOBEC3G Inhibits PERV Transmission
The second key step in addressing our experimental question was
isolating PK-15 clones that stably expressed human APOBEC3G.
Clones expressing human APOBEC3G cDNA or an empty vector
control were established in parallel (Figure 2A). Immunoblotting
identified clones with APOBEC3G levels similar to those in known
APOBEC3G-expressing human T cell lines CEM and H9, which
are non-permissive for growth of Vif-deficient HIV-1 [19].
Although it was impossible to achieve a physiologic expression
level, the comparative immunoblot at least ensured that the levels
of APOBEC3G were equal or lower than those present in well-
studied, non-permissive human T cell lines.
Co-culture experiments were set up to compare PERV trans-
mission from two independently derived PK-15 clones expressing
human APOBEC3G and two vector expressing controls. Re-
markably, the human APOBEC3G expressing PK-15 clones
showed levels of PERV transmission that were lower than the
Q-PCR detection threshold of approximately 10 copies (Figure 2B;
Figure 1. PERV Transmission Assay. (A) Schematic of the co-culture
system. PERV transmitting PK-15 cells are grown on top of the
membrane of the insert and human 293T cells on the bottom of the
well of the culture dish. Virus particles are depicted diffusing through
membrane pores. (B) The zoonotic transmission of PERV from PK-15
cells to 293T cells is shown by the time-dependent accumulation of
PERV pol gene DNA in the human cells (solid diamonds and squares).
No concomitant transfer of pig genomic DNA occurred through the
duration of these experiments (open diamonds and squares). This
graph summarizes data for two independently derived PK-15 clones, V1
(squares) and V2 (diamonds). All data points were calculated using
results from duplicate Q-PCR reactions of genomic DNA from three
parallel (but independent) co-cultures. The error bars indicate the SEM.
See the Materials and Methods and Online Figure S1 for additional
details, representative raw data and controls.
doi:10.1371/journal.pone.0000893.g001
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levels of PERV transfer by co-culture day 17 and transmission
events continued to accumulate through the duration of the
experiment. The kinetics of PERV transmission were similar to
those reported in Figure 1B (these results also contributed to the
aforementioned transfer rate calculations). These data were
further corroborated by additional experiments where PERV
transmission was monitored simultaneously by Q-PCR and by
reverse-transcriptase ELISA assays (Online Figure S2).
The Sub-cellular Distribution of Human APOBEC3G
Is Virtually Identical in Human and Pig Cell Lines
An ultimate application of the technology described here raises the
potential problem that human APOBEC3G may not be subjected to
(proper) post-translationalregulation inpig cells and itmay therefore
promote carcinogenesis. Expression of human APOBEC3G in
a heterologous system has been shown to trigger elevated levels of
genomic C/G-to-T/A transition mutation [44]. Therefore, to help
mitigate this risk (in addition to establishing clones that expressed
relatively modest APOBEC3G levels; above), we asked whether the
predominantly cytoplasmic localization pattern of human APO-
BEC3G would be maintained in PK-15 and in a swine testes cell
line, ST-IOWA (Figure 3; compare with other APOBEC3G reports
[18,35,41]). Unlike some other APOBEC3 proteins such as human
APOBEC3B, which is mostly nuclear, both human APOBEC3G
and pig APOBEC3F appeared predominantly cytoplasmic in either
the human or the pig cell lines (Figure 3; [28,31,41]). Both proteins
alsoappearedtoconcentrateincytoplasmicpunctae,whichvariedin
number and were apparent in some of the cells regardless of species
of origin (described previously for APOBEC3G; e.g., [45,46]).
Overall, these near-identical localization patterns suggested that
human APOBEC3G is not aberrantly regulated in pig cells and,
interestingly, that these proteins might be subjected to the same
cellular regulatory mechanism(s).
PERV Appears Resistant to Porcine APOBEC3F
During the course of these experiments, we reported some of the
activities of pig APOBEC3F [41]. It could strongly inhibit the
replication of HIV (regardless of Vif) and modestly inhibit the
replication of MLV, a gamma-retrovirus phylogenetically related
to PERV. Therefore, we wondered whether pig APOBEC3F was
expressed in PK-15 and, if so, whether PERV resists this cellular
defense. To begin to address this possibility, RT-PCR was used to
test PK-15 cells for pig APOBEC3F expression. Pig APOBEC3F
mRNA was detected readily (Online Figure S3A). Full cDNA
sequencing revealed that the predicted APOBEC3F protein of
PK-15 cells was 98% identical to the variant we reported
previously [41]. Eight amino acid differences were found, but
both the PK15 and the previously reported APOBEC3F sequences
were represented in pig genomic DNA sequences suggesting that
these may be breed-specific polymorphisms (R.S.L. and R.S.H.,
manuscript in preparation). These observations indicated that
either PERV resists the endogenous APOBEC3F protein of its
host or that the level of suppression by pig APOBEC3F is not
sufficient to inhibit PERV transmission.
To begin to distinguish between these two hypotheses, PK-15
clones over-expressing pig APOBEC3F were established and used
Figure 2. Human APOBEC3G Inhibits PERV Transmission. (A) An
immunoblot showing PK-15 clones expressing human APOBEC3G (G1
and G2) or a control vector (V1 and V2). PK-15 and 293T cell lysates
were used as negative controls. CEM and H9 were used as positive
controls for APOBEC3G expression. A non-specific (but pan-species)
band is shown as a protein loading control (marked by an asterisk). (B)
Q-PCR data using genomic DNA prepared from 293T cells co-cultured
with two independently derived APOBEC3G expressing PK-15 clones
(G1 and G2, circles and triangles, respectively) or two vector control
clones (V1 and V2, diamonds and squares, respectively). The
experimental parameters are identical to those used in Figure 1B.
doi:10.1371/journal.pone.0000893.g002
Figure 3. The Sub-cellular Distribution of Human APOBEC3G in
Human and Pig Cell Lines. Sub-cellular distributions of GFP, human
APOBEC3G-GFP and pig APOBEC3F-GFP in the indicated live pig and
human cell lines. The scale bar in the top left panel indicates 10 mM.
doi:10.1371/journal.pone.0000893.g003
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because pig APOBEC3F over-expression did not significantly
interfere with PERV transmission (Online Figure S3B). These
results were further supported by PCR experiments showing that
PERV could be amplified readily from 293T cells that had been
co-cultured with PK-15 over-expressing pig APOBEC3F (unlike
the APOBEC3G scenario; below).
We further noted that it is highly unlikely that another resident
APOBEC3 protein contributes to PERV restriction, because
genomic DNA sequencing showed that pigs have only one
APOBEC3 gene, APOBEC3F (R.S.L. and R.S.H., manuscript in
preparation). These observations combined to indicate that PERV
is resistant to the endogenous APOBEC3 protein of its host. In
hindsight, this was not particularly surprising given the emerging
trend that (successful) retroviruses are selected in part by their
ability to evade the APOBEC3 proteins of their host species (see
Introduction).
Evidence that Human APOBEC3G Inhibits PERV By
a Deamination-Independent Mechanism
The hallmark of APOBEC3G-dependent retrovirus restriction is
plus-strand G-to-A hypermutation, which is caused by the de-
amination of minus-strand cDNA C-to-U during reverse transcrip-
tion [17,18,20,24,25]. The deamination of cytosines within single-
strand DNArequiresglutamate259(E259)ofAPOBEC3G[47–49].
Based on homology to structurally defined deaminases, E259 likely
functions by helping position the water molecule that ultimately
initiates the deamination reaction by attacking the cytosine ring (as
a hydroxide; reviewed by [17,23,50,51]).
To determine whether DNA deamination is required the
APOBEC3G-dependent inhibition of PERV transmission, we
established a new set of PK-15 clones expressing APOBEC3G,
APOBEC3G E259Q or a vector control (Figure 4, inset).
Surprisingly, both APOBEC3G and the E259Q derivative
diminished PERV transmission to near background levels
(Figure 4). These data demonstrated that the mechanism of
inhibition does not require the DNA deaminase activity of
APOBEC3G. These data were further supported by the fact that
plus strand G-to-A hypermutations were not apparent in the DNA
of the rare transmission events that occurred in the presence of
human APOBEC3G (below).
Genetic Variation in Zoonosed PERV DNA Sequences
To begin to genotype the infectious PERVs and to further probe the
mechanism of PERV restriction by human APOBEC3G, the PERV
pol gene DNA was amplified from human 293T cells, cloned and
sequenced (Figure 5A; Online Figure S4). Twenty-nine and twenty-
two sequences were analysed from APOBEC3G and control
experiments, respectively. To minimize possible PCR biases, any
sequence that was recovered multiple times was considered one
event, unless it arose from independent experiments. These DNA
sequence analyses revealed several important points.
First, in contrast to vector control and pig APOBEC3F over-
expressing co-cultures, PERV pol gene DNA was difficult to
amplify from the genomic DNA of 293T cells that had been co-
cultured with APOBEC3G-expressing PK-15 cells (Figure 5B and
every significant sampling point in our Q-PCR experiments).
Taking this together with the observation that APOBEC3G does
not effect PK-15 virus production (similar RT levels were observed
in cell-free supernatants in the presence or absence of APO-
BEC3G; data not shown), we infer that APOBEC3G restricts
PERV transmission after virus production but before provirus
integration (i.e., between entry and integration). APOBEC3G may
restrict PERV at an early reverse transcription stage, possibly by
interfering with primer binding, DNA synthesis and/or integration
Figure 4. The APOBEC3G-dependent Inhibition of PERV Transmission
Is Deamination-Independent. PERV-specific Q-PCR data using genomic
DNA prepared from 293T cells co-cultured with PK-15 clones expressing
APOBEC3G (G; triangles), APOBEC3G-E259Q (GE259Q; circles) or empty
vector (V; squares). Two datasets, each with an independent PK-15
clone in three replica co-culture wells, were collected in parallel and
averaged for each data point. One standard error of the mean is shown.
The experimental parameters are identical to those used in Figure 1B.
The inset immunoblots show the APOBEC3G and a-tubulin levels of
representative PK-15 clones expressing the indicated construct. The
human T cell line H9 provided a positive control for APOBEC3G
expression.
doi:10.1371/journal.pone.0000893.g004
Figure 5. Genetic Variation in Zoonosed PERV DNA Sequences. (A) A
schematic of the PERV genome showing coding regions (gag, pol and
env) and long-terminal repeats (LTRs). The relevant 193 bp pol gene
fragment is indicated. (B) An ethidium bromide-stained agarose gel
showing that PERV pol gene DNA was amplified readily from 293T cells
cultured with PK-15 control clones (None) and pig APOBEC3F over-
expressing clones (A3Fo/e) but not with PK-15 clones expressing
human APOBEC3G (A3G; top panel). PERV pol gene DNA (top panel)
and pig genomic DNA (APOBEC3F locus; middle panel) PCR products
were detected in PK-15 genomic DNA, whereas human beta-actin was
strongly detected in the 293T cell genomic DNA samples (a much
weaker amplification of pig beta-actin occurred because the human
primers had partial complementarity to pig sequences, 20/21 and 17/18
nucleotides).
doi:10.1371/journal.pone.0000893.g005
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[30,52–55]).
Second, control co-culture PERV transmission events were
exceptionally diverse, as 11 unique pol sequences were detected
and only 4 were found multiple times (Online Figure S4). These
data suggested that PK-15 cells have at least 11 active PERVs
capable of infecting human 293T cells, a number consistent with
previous studies that reported the existence of approximately 17–
50 PERV copies in total (with only a fraction being replication-
competent; [11,12]). In contrast, the rare PERV sequences derived
from the APOBEC3G co-culture experiments showed a much
lower genetic complexity. Only three unique sequences were
recovered, each differing by a single nucleotide (Online Figure S4).
In parallel experiments with HIV-based viruses, this APOBEC3G
expression construct caused approximately 30 G-to-A hypermuta-
tions per 1000 bases analyzed (e.g., [41]). Thus, approximately 12
G-to-A transitions should have been recovered in these PERV
DNA analyses (nearly 90 if multiply recovered sequences would
have been considered). The absence of hypermutated PERV
proviral DNA provided further support for a deaminase-in-
dependent mechanism of restriction, which may share features
with other instances described previously (e.g., [27–30]).
DISCUSSION
We have established a quantitative assay to monitor the zoonotic
transmission of PERV to human 293T cells. Expression of human
APOBEC3G in the pig PK-15 cell line strongly inhibited PERV
zoonoses, while the endogenous APOBEC3F protein of pigs
appeared considerably less effective. These data are the first to show
that human APOBEC3G can inhibit PERV and the first to
demonstrate that APOBEC3 proteins can be used purposefully to
reduceifnotpreventzoonoticretroviralinfections.Theseresultswere
not anticipated because human APOBEC3G has a relatively weak
effect against the PERV-related gamma-retrovirus MLV [26,39].
Our data indicate that the engineering of pigs to express human
APOBEC3G (or an equally potent non-porcine APOBEC3) may
result in animals whose cells and tissues are much less likely to
disseminate functional PERV. The deamination-independence of
the restriction mechanism suggests that a catalytically inert
APOBEC3G protein, such as E259Q, may be equally potent
and simultaneously reduce the risk of cancer-promoting muta-
genesis. APOBEC3G or APOBEC3G-E295Q expressing pigs may
therefore constitute safer source animals for pig-to-human
xenotransplantation procedures. In contrast to knockdown, knock-
out (by gene targeting or selective breeding) or most chemical-based
anti-viral approaches to neutralize PERV [15], the APOBEC3 anti-
viral defense system has several advantages including a potentially
broad neutralizing activity (effective against PERV and likely several
other endogenous and exogenous viruses) and an applicability to
situations where many copies of a virus are already present in
a genome. Analogous transgenic applications can be envisaged, such
as using cross-species APOBEC3 expression to purposefully impede
known viruses (e.g., the AIDS virus HIV-1 or the Hepatitis B virus
HBV). Moreover, for humans and other mammals with multiple
APOBEC3 proteins, our data encourage the development of
methods to induce/up-regulate endogenous APOBEC3 proteins,
which have the capacity but may not normally restrict a particular
virus (e.g., human APOBEC3B and HIV-1).
MATERIALS AND METHODS
Cell lines, plasmids and co-culture experiments
The porcine kidney PK-15 fibroblast cell line and the swine testes
ST-IOWA cell line were obtained from the ATCC and cultured in
Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented
with 10% fetal bovine serum (Gemini), and 25 units/ml penicillin
and 25 mg/ml streptomycin at 37uC and 5% CO2. Human
embryonic kidney 293T and HeLa (A. Bielinsky, University of
Minnesota) cell lines were grown under the same conditions. The
T cell lines H9 and CEM (M. Malim, Kings College London) were
cultured in RPMI-1640 supplemented with 10% fetal bovine
serum (Gemini), and 25 units/ml penicillin and 25 mg/ml
streptomycin at 37 uC and 5% CO2. Plasmids encoding human
APOBEC3G, human APOBEC3G-E259Q and porcine APO-
BEC3F were described previously [41]. The human APOBEC3G
and porcine APOBEC3F cDNA sequences used here are
identical to GenBank accession numbers, NM_021822 and
NM_001097446, respectively.
Stable APOBEC3G- or vector control-expressing PK-15 cell
lines were constructed by transfection using FuGENE6 according
to the manufacturer’s protocol (Roche) or by electroporation
(BioRad, 250V, 950 mFa). Clones were selected using growth
medium containing 1 mg/ml G418 (Roche), and APOBEC3G
expressing clones were identified by immunoblotting using a poly-
clonal antibody toward human APOBEC3G (J. Lingappa,
University of Washington). All PK-15 clones were maintained in
growth medium supplemented with 250 mg/ml G418 to ensure
stable expression.
Long-term co-culture assays were performed in 6 well tissue
culture plates with inserts (TranswellH, Corning Inc.). This system
uses a membrane with 0.4 mM diameter pores, which keeps the
two cell types separated physically but simultaneously allows
diffusion of nutrients and small molecules including virus particles
of approximately 0.1 mM (including PERV). Each experiment was
initiated with 75,000 PK-15 cells (insert) and 75,000 293T cells
(well) as illustrated (Figure 1A). At 72 hr intervals, each cell type
was washed with PBS, subjected to mild trypsinization and diluted
into 4 parts fresh growth medium. Excess 293T cells were used to
prepare genomic DNA (Qiagen DNeasy kit).
The rate of PERV transfer was calculated using the pol gene
levels from the last two data points (usually spanning a 3 day
period). The difference between these levels represents PERV pol
gene DNA that has accumulated per 100,000 human beta-actin gene
copies (50,000 cells assuming that the 293T cell line has two beta-actin
copies) per time period. Individual rates from 5 independent
experiments were averaged to determine the overall transmission
rate (190+/262 events per day per 50,000 cells). Data from
Figures 1B, 2B and S2A contributed to rate calculations.
Genomic DNA Q-PCR assays
Genomic DNA was isolated from human 293T cells using the
DNeasy kit (Qiagen). Duplicate 25 ml PCR reactions consisting of
10 ng of 293T genomic DNA, 100 nM primers and 26iQ SYBR
Green super mix (BioRad) were run on an iCycler iQ Multicolor
Real-Time PCR detection System (BioRad). The thermocycler
conditions consisted of an initial denaturation of 95uC for 5 min
and 50 cycles of denaturation (95uC for 15 sec) and annealing
(58uC for 30 sec). After the 50 cycles, a melting curve analysis
(55uCt o9 5 uC) was performed to confirm product specificity. The
cycle threshold (CT) was generated using BioRad software and it
was used to calculate the amount of target DNA (PERV pol or
human beta-actin). A standard curve was generated using the
method of Dorak [56] and a dilution series (10 to 10
7 copies) of
a linearized plasmid containing the relevant 193 bp PERV pol
gene fragment. The equation generated from the standard curve
(slope and y intercept) was used to determine the efficiency of the
PCR reaction and to quantify the number of PERV pol gene or
human beta-actin copies in the Q-PCR reactions. PERV copy
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[56]. The primer sets used in this study were: PERV pol (193 bp):
59-AAC CCT TTA CCC TTT ATG TGG AT and 59-AAA GTC
AAT TTG TCA GCG TCC TT; human beta-actin (133 bp)[57]:
59-ATC ATG TTT GAG ACC TTC AA and 59-AGA TGG
GCA CAG TGT GGG T; pig genomic DNA (341 bp product
specific to intron 5 of the pig APOBEC3F locus): 59-TGG GGA
GTG TGG AAT TAA CG and 59-GGG GGT TAA GAA CCC
AAC AT.
RT-PCR experiments
Standard reverse transcription (RT)-PCR reactions were per-
formed using RNA prepared from PK-15 cells (TRIzol protocol,
Invitrogen), M-MLV reverse transcriptase was used for cDNA
synthesis using an oligo dT primer (Ambion) and Taq polymerase
was used for PCR (Roche). The primers specific to pig
APOBEC3F were 59-TGG TCA CAG AGC TGA AGC AG
and 59-TTG TTT TGG AAG CAG CCT TT (175 bp). The
semi-nested primer set used to detect plasmid-expressed pig
APOBEC3F was 59-CCA AGG AGC TGG TTG ATT TC (exon
6, reaction 1), 59-CTG GAG CAA TAC AGC GAG AG (exon 7,
reaction 2) and 59-TAG AAG GCA CAG TCG AGG, with the
latter being vector specific (319 bp and 190 bp products, re-
spectively). The mammalian beta-actin primers were 59-CCT TCA
ATT CCA TCA TGA AGT G and 59-CCA CAT CTG CTG
GAA GGT (236 bp). These primers amplify equally well a 236 bp
beta-actin fragment from all mammals tested, including pigs and
humans (e.g., Online Figure S3).
Fluorescent microscopy
The human APOBEC3G-GFP, pig APOBEC3F-GFP and GFP
expression constructs were described previously [28,41]. The pig
and human cell lines were maintained as above. One day prior to
transfection, 5,000–20,000 cells were seeded onto LabTek
chambered coverglasses (Nunc). After 24 hrs incubation, these
cells were transfected with 250 ng of the relevant plasmid
construct. After 24 hrs of additional incubation, images of the
live cells were acquired using a Zeiss Axiovert 200 microscope at
4006 total magnification. Images were analyzed using Image J
software (http://rsb.info.nih.gov/ij).
Reverse transcriptase activity assays
Whole cell protein extracts were prepared from 293T cells by
suspending 500,000 cells in PBS, sonicating twice for 5 seconds
and clarifying the lysates by centrifugation. Soluble protein levels
were quantified using a BioRad Bradford assay. 10 mg of cell lysate
was tested for reverse transcriptase activity using a C-type-RT
activity assay (Cavidi Tech) following the manufacturers’ instruc-
tions. Cell-free PK-15 supernatants (PERV-containing) were
assayed directly using the Cavidi Tech ELISA assay.
PERV pol gene DNA sequence analyses
Human 293T cell genomic DNA was prepared from terminal co-
cultures and 50 ng was used for high fidelity, PERV pol gene-
specific PCR reactions (Phusion polymerase; Finnzymes). 193 bp
products were cloned using the Zero Blunt TOPO PCR Cloning
kit (Invitrogen) and sequenced (University of Minnesota Advanced
Genetic Analysis Facility). Sequence comparisons were performed
using Sequencher software (Gene Codes Corp.) and publicly
available Clustal W alignment algorithms (http://align.genome.
jp/).
SUPPORTING INFORMATION
Figure S1 Quantitative Real-time PCR Analyses. (A) Standard
curves depicting Q-PCR data obtained using dilutions of
a linearized PERV pol gene plasmid alone (squares) or diluted
plasmid plus 10 ng of 293T cell genomic DNA (diamonds). Under
both conditions, all template amounts (10 to 10
7 copies) amplified
efficiently (the log-linear slope equations are shown). The
correlation co-efficiency value (R
2), which reports the technical
accuracy of the assay, is also indicated. The standard curve data
points were the average of 2 independent reactions with deviations
smaller than the symbols (i.e., C
T errors for each point ranged
from 0 to 0.4). (B) Two representative control Q-PCR datasets
showing the amplification of PERV pol gene DNA from pig PK-15
cell genomic DNA (circles). Two additional control Q-PCR
datasets showing that the PERV-specific primers fail to amplify
product from uninfected human 293T cell genomic DNA
(squares). The reaction threshold, 10 times the mean standard
deviation of the background fluorescence level (BioRad), is
indicated. (C) Representative co-culture Q-PCR amplification
curves of PERV pol gene DNA. Template genomic DNA isolated
from human 293T cells co-cultured with vector expressing PK-15
cells (diamonds) or human APOBEC3G-expressing PK-15 cells
(triangles) was used. (D) Representative Q-PCR amplification
curves of the 293T cell beta-actin gene, which served as an internal
standard for quantifying the real-time PCR data. Raw Q-PCR
data will be made available on request.
Found at: doi:10.1371/journal.pone.0000893.s001 (9.93 MB TIF)
Figure S2 APOBEC3G inhibits PERV transmission. (A) A
graph showing the accumulation of PERV pol gene-specific PCR
products in 293T cells co-cultured with a control cell line (V3) but
not with an APOBEC3G-expressing cell line (G1). The data points
were an average of two Q-PCR runs and the difference between
each run was smaller than the plotted symbol. The experimental
parameters were identical to those used in the experiments shown
in Figures 1B and 2B. (B) Relative levels of reverse transcripta-
se(RT)-activity detected in soluble extracts of day 28 co-cultured
293T cells, which were used to generate the Q-PCR data shown in
Figure S2A. Uninfected 293T cell lysates had a relatively high
endogenous RT activity. Therefore, to help with the presentation
of these data, this level was normalized to one and all of the other
data were calculated relative to this value. The level of RT activity
in PK-15 extracts was much higher than that of 293T cell extracts
(+/2PERV) and it had reached saturation (out of range) when
these data were collected.
Found at: doi:10.1371/journal.pone.0000893.s002 (4.76 MB TIF)
Figure S3 Pig APOBEC3F Is Expressed in PK-15 Cells and its
Over-expression Does Not Markedly Inhibit PERV Transmission.
(A) An image of an ethidium bromide-stained agarose gel showing
the results of an RT-PCR amplification experiment using PK-15
cellular RNA and appropriate controls. The top panel shows that
PK-15 and representative PK-15 derived clones all expressed pig
APOBEC3F, as indicated by the specific 175 bp pig APOBEC3F
PCR product (confirmed by DNA sequencing). 293T cell mRNA
and a diluted pig APOBEC3F expression plasmid were used as
negative and positive controls, respectively. A larger, non-specific
band was apparent only in the 293T cell RT-PCR reactions. The
bottom panel shows that a conserved, 236 bp beta-actin gene
fragment could be amplified from both PK-15 cells and human
293T cells (but not from diluted plasmid DNA). Note that this
primer set differs from the human-specific set used in the Q-PCR
experiments. The sizes of the marker (M) DNA bands are shown.
(B) An image of an ethidium bromide-stained agarose gel showing
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26 days of continuous co-culture. Non-transfected (NT) cells and
diluted APOBEC3F plasmid DNA (pDNA) provided negative and
positive controls, respectively. The larger 319 bp (far right lane
only) and smaller 190 bp bands are the specific PCR products of
the first and second rounds of semi-nested PCR, respectively
(confirmed by DNA sequencing). (C) A histogram summarizing
the level of PERV transmission that was observed after 23 days of
co-culturing human 293T cells with PK-15 cells expressing a vector
control or over-expressing pig APOBEC3F. Two datasets, each
with an independent PK-15 clone in three replica co-culture wells,
were collected in parallel and averaged for each histogram bar.
One standard error of the mean is shown. The experimental
parameters are identical to those used in Figure 1B.
Found at: doi:10.1371/journal.pone.0000893.s003 (8.52 MB TIF)
Figure S4 Genetic Variation in Zoonosed PERV pol Gene
Sequences. (A) Sequences of the PERV pol gene fragments cloned
from 293T cells co-cultured with control vector-expressing PK-15
cells. The number of times that each sequence was recovered is
shown (N). Experiments 1 and 2 used genomic DNA prepared
from the 293T cells used to generate the data shown in Online
Figure S2 (day 28 samples) and Figure 2B (day 23), respectively.
The most frequently detected 147 bp PERV pol gene sequence is
shown in its entirety (which together with PCR primers makes up
the 193 bp product shown in Figure 5). Identical nucleotides in
other sequences are represented by dashes and non-identical
nucleotides by the indicated DNA bases. GenBank accession
numbers are shown for pol gene fragments with 100% identity to
previously reported sequences. (B) Sequences of the PERV pol
gene fragments cloned from 293T cells co-cultured with control
APOBEC3G-expressing PK-15 cells. Parameters are identical to
those described above.
Found at: doi:10.1371/journal.pone.0000893.s004 (0.05 MB
DOC)
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